Background and Objective: Photodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the bloodbrain barrier (BBB). We have evaluated the ability of ALAmediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. Study Design/Materials and Methods: ALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T 1 -weighted high field (3 T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized. Results: PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100% restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA. Conclusion: ALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.
INTRODUCTION
Despite improvements in currently employed treatment methods for malignant gliomas including surgical tumor resection, radio-and/or chemotherapy, patient prognosis remains poor. Malignant cells of these high-grade gliomas exhibit migratory behavior, possibly owing to their developmental character within the CNS and, as a consequence, patients relapse in almost all cases with recurrent tumor growth within a 2-3 cm margin of the surgical resection cavity [1] . This appears to be the rule even in cases where post-operative MRI shows no residual tumor. The CNS is protected from circulating toxins by the relatively impenetrable BBB. The BBB prevents passage of ionized watersoluble molecules with molecular weight greater than 180 Da as well as large lipophilic compounds [2] . Consequently, the BBB limits the delivery of potentially effective diagnostic or therapeutic agents and this is probably the reason that chemotherapy has only contributed marginal patient benefit [3] . Although the BBB may be partially disrupted in gliomas, as shown experimentally by the uptake of horseradish peroxidase [4] , clinically by improved visualization of the tumor by contrast-enhanced magnetic resonance imaging (MRI), or fluorescence measurements following the injection of photosensitizers [5] , the brain adjacent to tumor (BAT) is characterized by relatively intact barriers. Therefore, even if the main tumor mass has a permeable vascular endothelium, the peripheral BAT region, which contains infiltrative tumor cells, has decreased permeability to anti-tumor agents. This poses a significant therapeutic challenge since these infiltrative tumor cells are protected by a patent BBB. For a drug delivery system to be successful at preventing tumor recurrence, transient and localized targeting of BBB disruption in the wall of the resection cavity following surgical removal of the bulk tumor, is necessary.
PDT is a local antineoplastic treatment with the potential for tumor cell specificity. The treatment involves the administration of a tumor-localizing photosensitizing agent followed by photo activation within the malignant tissue [6] . Several studies have shown that PDT may prove useful in prolonging survival and/or improving the qualityof-life in glioma patients [7] [8] [9] . PDT has several features that makes it a potentially effective adjuvant therapy for the treatment of brain tumors: (1) PDT is a local form of treatment in which the treated volume is limited by high attenuation of light in brain tissues and, (2) repeated application of PDT is an option due to low long-term morbidity.
The aim of PDT is to eliminate the nests of tumor cells remaining in the margins of the resection cavity following surgical removal of the bulk tumor while causing minimum damage to the surrounding brain tissue. In particular, PDT delivered in repetitive form has been shown in both experimental and clinical studies to have clear advantages over single treatments [9] [10] [11] .
PDT using either hematoporphyrin derivatives or ALA has been reported to induce brain edema [12] [13] [14] [15] . The edema region surrounding the site of light treatment suggests a local degradation of the BBB. PDT therefore appears to have a twofold effect; a direct antineoplastic effect on the remaining tumor cells as well as an effect that results in localized opening of the BBB allowing chemotherapeutic agents to penetrate into the BAT region.
The present study investigates changes in the BBB following ALA-PDT in normal rodent brain. The use of MRI allows for a more detailed study of the dynamics of bloodbrain barrier degradation following PDT compared to that which can be obtained with more conventional methods. MRI scans at 3 T following intra-peritoneal gadolinium (Gd) contrast administration allowed for a highly detailed spatial and temporal analysis of the BBB opening.
MATERIALS AND METHODS

Experimental Animals
Inbred male Fischer 344 rats (Simonsen Laboratories, Inc., Gilroy, CA) weighing at least 300 g were caged in Macrolon III cages. The animal holding rooms were maintained at constant temperature and humidity on a 12-hour light and dark schedule at an air exchange rate of 18 changes per hour. Animal care and protocol were in accordance with institutional guidelines. For the surgical procedures, the rats were anaesthetized with pentobarbital (25 mg/kg i.p.). Buprenorphin (0.08 mg/kg s.c.) was used as a post-operative analgesic. The animals received a total of seven doses administered at 12-hour intervals. All animals were euthanized with Pentobarbital (100 mg/kg i.p.) at the first signs of distress.
PDT Treatment Protocol
Four to five hours following ALA administration (125 mg/ kg i.p), the animals were anaesthetized and fixed in a stereotactic frame. A skin incision was opened and a 1 mm burr hole was made. A 400 mm bare flat-end quartz fiber with numerical aperture 0.22 was introduced stereotactically directly into the brain to a depth of 5 mm below the dura. Light from a 632 nm diode laser was delivered interstitially to various fluence levels at different fluence rates over a time interval ranging from 10 to 90 minutes. After treatment, the fiber was withdrawn and closure was performed with bone wax and sutures.
Magnetic Resonance Imaging
Fischer rats were imaged in a 3.0 T human MR scanner (Achieva X-series, Philips Medical Systems, Bothell, WA). At various times following treatment, animals were anesthetized and subjected first to T2-weighted (TR ¼ 3,560 milliseconds; TE ¼ 80 milliseconds) fast spin echo pulse sequences followed by T1-weighted fast spin echo pulse sequences (TR ¼ 495 milliseconds; TE ¼ 10 milliseconds, slice thickness ¼ 1.0 mm) obtained before and after a subcutaneous injection of Gd contrast (1.0 ml of 0.5 mmol/ml Magnevist: Berlex Laboratories, Wayne, NJ). In the post-contrast studies, images were acquired over a time interval of 10-60 minutes following Gd administration. In all cases, animals were imaged using a receiver coil designed for scanning the human shoulder.
The estimation of Gd concentration was performed as follows. Four calibration tubes with known Gd concentrations in saline were scanned and the intensities analyzed (Fig. 1a) . It was assumed that the relationship between the Gd concentration and the signal intensity in white and gray matter were similar to that of the calibration tubes, and therefore the calibration curve derived from these measurements could be extrapolated to brain tissue (Fig. 1b) .
Histological Preparation
Animals were sacrificed 14 days following PDT treatment and their brains extracted. The brains were sectioned along the fiber injection track and fixed by immersion in 10% buffered (pH 7.2) formalin prior to paraffin embedding. Four micrometer thick coronal sections were obtained from the original cut surface representing the position of the fiber track and thereafter at 1, 2, and 3 mm depths. The sections were stained with hematoxylin and eosin (H&E) and examined under a light microscope by an independent pathologist blinded to the treatment modes.
Data Analysis
Contrast volume and intensity were analyzed using OsiriXVP software on a Mac OS platform. Contrast volumes were outlined on each T1 contrast slice and calculated according to the following equation: V ¼ (SiÂ0.15) cm 3 where Si represents the contrast area calculated on each 1.5 mm thick slice.
RESULTS
Local PDT-Induced BBB Disruption
Localized regions of increased signal intensity on T1-weighted MRI scans were used as a marker of BBB disruption in the rat brain. Both the volume of the enhancing region and the signal intensity were measured at a specific time interval following i.p. contrast injection. Four to five hours following ALA injection (125 mg/kg i.p.) light treatment was given to three groups of rats (n ¼ 6 per group) to a fluence level of 9, 17 or 26 J using a fluence rate of 10 mW. Figure 2a ,b illustrate typical post-contrast MRI scans performed 3-4 hours after PDT treatment. A fluence level of either 9 or 17 J was used and the scans taken 15 minutes following i.p. contrast injection. Clear evidence of local BBB disruption is seen at both fluence levels as evidenced by the localized contrast enhancement (Fig. 2a,b ) centered around the stereotactic placement position of the light delivery fiber tip. Figure 3 shows the average volume of contrast enhancement measured from MRI scans performed post-treatment for the three light fluences. A significant light dose response effect was apparent, with increasing light fluence giving increased contrast volume indicating an increasing disruption of the BBB. Similar results were seen for enhancement intensity as shown in Figure 4a . The concentration of the contrast medium (calculated from the calibration curve in Fig. 1 ) is shown in Figure 4b . Contrast concentrations between 125 and 710 mg/ml were obtained for the three fluence levels examined (9-26 J). In the absence of ALA (light-only control), high fluences (26 J) demonstrated no apparent increased signal level in the region of light treatment compared to normal brain.
In a separate set of experiments designed to evaluate fluence rate effects, rats were treated to a total fluence of 26 J delivered at 10, 30, or 50 mW. The effects of fluence rate on contrast volume are shown in Figure 5 . Increased fluence rates gave not only increased contrast volume but increased signal intensity as well, indicating an increased contrast concentration. 
Time Course of BBB Opening and Closing
One group of four animals was subjected to a fluence of 9 J while another four rats were treated to a fluence level of 17 J. In both cases, light was delivered at a fluence rate of 10 mW. The animals were scanned 2-4 hours following treatment and rescanned 1, 3, 7, and 17 days posttreatment. The animals were scanned 15 minutes. following i.p. contrast injection. Figure 6 shows the T1 contrast images from one of the animals in each group scanned shortly after PDT and 24 and 72 hours following light treatment. A localized contrast enhancement is clearly seen 2-4 hours following light treatment at both fluence levels. For a fluence of 9 J, the BBB was restored by day 3 (Fig. 6c) . For higher fluence levels (17 or 26 J), the BBB disruption lasted for a longer duration and, in some cases, was still not completely restored by day 17. Figure 7 illustrates the increase of T1 signal intensity with time post-contrast injection on day 1 and 7 following light treatment. The signal intensity 24 hours following PDT treatment and 60 minutes post-contrast injection was considered as the 100% point. The rate of flow was clearly biphasic on day 1 with a rapid increase in intensity during the initial 10 minutes. following contrast injection and thereafter decreasing to a much lower rate following the initial contrast influx. Interestingly, a linear increase in average intensity with time was observed on all subsequent scanning days in all the animals tested.
Contrast flow rate, based on increasing volume of T1 signal enhancement, on each of these days was calculated by rescanning the rats at several intervals following contrast injection. The combined average results for a fluence level of 17 J for all four animals are shown in Figure 8 . The rate of flow fell rapidly from 7 to 1.3 ml/minutes (80% decrease) from day 0-1 to day 3. Thereafter, the flow rate decreased at a decreasing rate and approximated base line flow after 17 days.
Histological Analysis
In areas exposed to the highest fluence levels (5-15 mm from the fiber), no significant pathology was observed in coronal sections obtained from animals subjected to fluences of 9 J (Fig. 2c) . At higher fluence levels of 17 J, extensive infiltration of lymphocytes and macrophages (some loaded with hemosiderin) was apparent (Fig. 2d) . Blood vessels in these sections showed hyperplastic endothelial cells. At fluence levels of 26 J, a focally extensive area of necrosis with some degeneration of brain parenchyma and infiltration of lymphocytes, plasma cells Figure 1 . Contrast concentrations between 125 and 710 mg/ml were obtained for the three fluence levels examined. and foamy macrophages (Gitter cells), was apparent in the immediate area of the fiber tip. Some of the Gitter cells contained hemosiderin which is suggestive of treatmentinduced hemorrhage. Blood vessels in these sections also showed hyperplastic endothelium. In contrast, sections taken 1, 2 or 3 mm from the fiber track showed no significant pathology for all three of the fluence levels tested.
Histological sections taken from the brains of light-only control animals showed no pathology. Contrast flow rate, based on increasing volume of T1 signal intensity, on each of these days was calculated by rescanning the rats at several intervals following contrast injection. The rate of flow fell rapidly from 6.7 to 1.3 ml/minutes (80% decrease) from day 1 to day 3. PDT treatment was performed 4 hours following i.p. injection of 125 mg/kg ALA. All animals were subjected to light fluence and fluence rates of 17 J and 10 mW, respectively.
DISCUSSION
The limited access of therapeutic agents into tumor infiltrated brain resulting from the presence of the BBB emphasizes the need for developing strategies for bypassing the BBB. The BBB is a specialized vascular system consisting of endothelial cells with highly selective membranes connected by tight junctions. Molecular size, charge and lipid solubility are the primary factors that limit passage of drugs through the BBB. Attempts to develop pharmaceuticals capable of circumventing the BBB, such as lipid-soluble or water-soluble drugs with high affinities for natural carriers [17, 18] have proven only partially successful. Intra-arterial infusion of mannitol, which causes dehydration and shrinkage of endothelial cells, results in opening of the tight junctions and a non-localized BBB disruption. This widespread opening of the BBB results in unwanted side effects since potent cytotoxic drugs gain access to both the tumor as well as normal brain in equal quantities. Treatment-related toxicity [19] as well as a number of technical difficulties associated with intraarterial drug delivery, have prevented the widespread use of this technique.
Localized methods of drug delivery that bypass the BBB altogether, such as direct intratumoral injection [20, 21] convection-enhanced delivery [22] [23] [24] and controlled release from polymer implants [25, 26] can carry an increased risk of morbidity and mortality and have only shown a modest benefit. Focused ultrasound offers a method to disrupt the BBB non-invasively and reversibly at targeted locations [27, 28] . This technique though is not well suited to the complex geometry or size of a postoperative resection cavity.
In this study we have shown that the commonly used MRI contrast agent Gd-DTPA (molecular weight: 938), was clearly evident in a localized region in the immediate vicinity of the illuminating fiber. Since Gd-DTPA does not pass the intact BBB, leakage of this contrast agent, and the resulting increased signal intensity on MRI scans, was used as a surrogate for a putative anti-cancer agent. In a recent study using ultrasound to open the BBB, Treat et al. [28] found a strong correlation between MRI signal intensity and the concentration of Doxorubicin in the targeted regions of the brain. These findings indicate that contrast enhanced MRI is a useful non-invasive tool in predicting the degree of penetration of chemotherapy agents through the disrupted BBB.
The volume and concentration of contrast was found to be light dose dependent (Figs. 3 and 4) . PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. This suggests the possibility of adjusting the drug penetration into the tissue. This has to be balanced with the observation that fluences over 9 J resulted in a certain amount of local tissue damage which suggests an upper limit to the maximum fluence that can be employed. In addition, fluence rates over 10 mW induced pronounced brain edema which often led to increased morbidity and even death.
No effect on the BBB was observed if 26 J of light was given in the absence of ALA. This indicates that neither the direct trauma of fiber insertion, or thermal effects caused by light energy absorption, played a significant role in BBB disruption.
The degradation of the BBB was temporary in nature, opening rapidly following treatment and significantly restored during the ensuing 72 hours. The BBB was found to be disrupted as early as 2 hours following PDT and approximately 90% restored 72 hours later. From a therapeutic standpoint, this time window is sufficient for the application of anti-cancer agents.
The mechanisms by which PDT leads to BBB degradation are uncertain but they likely include direct PDT effects on the endothelial cytoskeleton that lead to cell rounding and contraction, probably mediated by PDT-induced microtubule depolarization [29] . In addition the formation and/or enlargement of endothilial gaps, has been observed in response to PDT [30] .
In previous fluorescence microscopy studies [5] , ALAinduced protoporphyrin IX (PpIX) fluorescence dropped sharply at the tumor/brain border. Even so, some PpIX fluorescence was apparent in presumptive normal brain in close proximity to the boundary. For example, at 1 and 2 mm from the tumor/brain boundary, the fluorescence was 13% and 2.5% of that observed in bulk tumor, respectively. This indicates that a direct effect on the capillary endothelial cells is the most probable cause for the BBB degradation.
Low fluence rate/low fluence PDT has been demonstrated to enhance the delivery of macromolecular drug carriers, in particular liposomally encapsulated doxorubicin (Doxil) into murine colon carcinoma tumors growing in the shoulders of mice [31] . We have also observed a significant increase in edema formation, in orthotopic brain tumors, following ALA-mediated PDT in a rat brain tumor model indicating a breakdown of the blood-tumor barrier (BTB) [5, 14] . In these cases, the BTB was significantly altered by PDT most probably in a similar manner to the one proposed here for the BBB by enlarging endothilial gaps. In a recent article, Hu et al. [32] , using a rat C6 glioma model and electron microscopy, showed that PDT changed the subcellular structure of the BTB with a reduction in the number of cellular components in endothelial cells of the capillary blood vessels. They also observed stretching of the tight junctions, with an enlargement of the gaps between endothelial cells and. In addition, PDT was found to have only a minimal impact on the normal sub-cellular structures of the BBB suggesting that the endothelial cells comprising the BBB were not permanently damaged by the treatment. These observations are in good agreement with the findings of this study which showed that low fluence PDT was capable of inducing BBB disruption, as evidenced by contrast enhancement on MR images, yet no permanent damage was found in histological sections (Fig. 2) . In contrast, the results of the present study clearly show that high fluence levels are capable of causing significant tissue damage. For example, the tissue damage and immune cell infiltration observed in the region in close proximity to the light source are consistent with cerebral ischemia resulting in a localized stroke. Contrast enhancement following Gd-DTPA injection is considered to be one of the signatures of BBB breakdown in cerebral ischemia. The region of tissue damage was limited in extent, and sections 1 mm from the point of maximum light intensity were unaffected. In a clinical setting, with light delivered directly into the wall of the tumor resection cavity, a much lower fluence rate would be applied to the surrounding brain. PDT could therefore offer an alternative to other strategies that have been developed to circumvent the BBB. For a drug delivery system to be successful, transient, and localized targeting of BBB disruption is necessary. PDT applied through an indwelling balloon applicator filling the resection cavity, could meet this requirement [33] .
In this study we have demonstrated that ALA-mediated PDT causes disruption of the BBB in a fluence and fluence rate dependent manner. At low fluence levels, the duration of BBB opening was less than 72 hours following treatment. No permanent tissue damage was observed in this case. Although the degree of BBB disruption was greater at higher fluence levels, damage to the surrounding tissue was evident. Localized T1-weighted MRI signal intensity observed following contrast injection proved to be a highly effective and non-invasive modality for following the development of the degree and time course of BBB dysfunction thus allowing the use of fewer animals.
